P2X7 receptor regulates leukocyte infiltrations in rat frontoparietal cortex following status epilepticus

Journal of Neuroinflammation

Volumn 7, Issue , 2010, Pages

  Kim, Ji Eun ^a   Ryu, Hea J ^a   Yeo, Seong Il ^a   Kang, Tae Cheon ^a  

^a Hallym University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' O (4 BENZOYLBENZOYL) ADENOSINE 5' TRIPHOSPHATE; ADENOSINE 5' TRIPHOSPHATE 2',3' DIALDEHYDE; ADENOSINE TRIPHOSPHATE DERIVATIVE; CD68 ANTIGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; PILOCARPINE; PURINERGIC P2X7 RECEPTOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG; CCL2 PROTEIN, RAT; CD68 ANTIGEN, HUMAN; CXCL2 CHEMOKINE; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; FRONTAL CORTEX; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MONOCYTE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PARIETAL LOBE; PROTEIN SECRETION; PYRIFORM CORTEX; RAT; ANIMAL; CELL COUNT; CHEMICALLY INDUCED DISORDER; FRONTAL LOBE; IMMUNOLOGY; METABOLISM; NERVE CELL; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL COUNT; CHEMOKINE CCL2; CHEMOKINE CXCL2; FRONTAL LOBE; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; MALE; NEURONS; NEUTROPHIL INFILTRATION; PARIETAL LOBE; PEROXIDASE; PILOCARPINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2X7; STATUS EPILEPTICUS;

EID: 77957730988     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-7-65     Document Type: Article

References (85)

1. Mathern GW, Babb TL, Pretorius JK, Melendez M, Levesque MF. The pathophysiologic relationships between lesion pathology, intracranial ictal EEG onsets, and hippocampal neuron losses in temporal lobe epilepsy. Epilepsy Res 1995, 21:133-147. 10.1016/0920-1211(95)00014-2, 7588588.
2. Wittner L, Magloczky Z, Borhegyi Z, Halasz P, Toth S, Eross L, Szabo Z, Freund TF. Preservation of perisomatic inhibitory input of granule cells in the epileptic human dentate gyrus. Neuroscience 2001, 108:587-600. 10.1016/S0306-4522(01)00446-8, 11738496.
3. De Simoni MG, Perego C, Ravizza T, Moneta D, Conti M, Marchesi F, De Luigi A, Garattini S, Vezzani A. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 2000, 12:2623-2633. 10.1046/j.1460-9568.2000.00140.x, 10947836.
4. Plata-Salamán CR, Ilyin SE, Turrin NP, Gayle D, Flynn MC, Romanovitch AE, Kelly ME, Bureau Y, Anisman H, McIntyre DC. Kindling modulates the IL-1beta system, TNF-alpha, TGF-beta1, and neuropeptide mRNAs in specific brain regions. Brain Res Mol Brain Res 2000, 75:248-258. 10.1016/S0169-328X(99)00306-X, 10686345.
5. Rizzi M, Perego C, Aliprandi M, Richichi C, Ravizza T, Colella D, Velískǒvá J, Moshé SL, De Simoni MG, Vezzani A. Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development. Neurobiol Dis 2003, 14:494-503. 10.1016/j.nbd.2003.08.001, 14678765.
6. Vezzani A, Conti M, De Luigi A, Ravizza T, Moneta D, Marchesi F, De Simoni MG. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 1999, 19:5054-5065.
7. Vezzani A, Moneta D, Conti M, Richichi C, Ravizza T, De Luigi A, De Simoni MG, Sperk G, Andell-Jonsson S, Lundkvist J, Iverfeldt K, Bartfai T. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci USA 2000, 97:11534-11539. 10.1073/pnas.190206797, 17235, 11016948.
8. Combrinck MI, Perry VH, Cunningham C. Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience 2002, 112:7-11. 10.1016/S0306-4522(02)00030-1, 12044467.
9. Cunningham LA, Wetzel M, Rosenberg GA. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 2005, 50:329-339. 10.1002/glia.20169, 15846802.
10. Layé S, Parnet P, Goujon E, Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res Mol Brain Res 1994, 27:157-162. 10.1016/0169-328X(94)90197-X, 7877446.
11. Pitossi F, del Rey A, Kabiersch A, Besedovsky H. Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice. J Neurosci Res 1997, 48:287-298. 10.1002/(SICI)1097-4547(19970515)48:4<287::AID-JNR1>3.0.CO;2-7, 9169855.
12. Bymaster FP, Carter PA, Yamada M, Gomeza J, Wess J, Hamilton SE, Nathanson NM, McKinzie DL, Felder CC. Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity. Eur J Neurosci 2003, 17:1403-1410. 10.1046/j.1460-9568.2003.02588.x, 12713643.
13. Turski WA, Cavalheiro EA, Schwarz M, Czuczwar SJ, Kleinrok Z, Turski L. Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav Brain Res 1983, 9:315-336. 10.1016/0166-4328(83)90136-5, 6639740.
14. Mello LEA, Cavalheiro EA, Tan AM, Kupfer WR, Pretorius JK, Babb TL, Finch DM. Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia 1993, 34:985-995. 10.1111/j.1528-1157.1993.tb02123.x, 7694849.
15. Mathern GW, Babb TL, Vickrey BG, Melendez M, Pretorius JK. The clinical-pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy. Brain 1995, 118:105-118. 10.1093/brain/118.1.105, 7894997.
16. Marchi N, Oby E, Batra A, Uva L, De Curtis M, Hernandez N, Van Boxel-Dezaire A, Najm I, Janigro D. In vivo and in vitro effects of pilocarpine: relevance to ictogenesis. Epilepsia 2007, 48:1934-1946. 10.1111/j.1528-1167.2007.01185.x, 17645533.
17. Biagas KV, Uhl MW, Schiding JK, Nemoto EM, Kochanek PM. Assessment of posttraumatic polymorphonuclear leukocyte accumulation in rat brain using tissue myeloperoxidase assay and vinblastine treatment. J Neurotrauma 1992, 9:363-371. 10.1089/neu.1992.9.363, 1337917.
18. Holmin S, Söderlund J, Biberfeld P, Mathiesen T. Intracerebral inflammation after human brain contusion. Neurosurgery 1998, 42:291-299. 10.1097/00006123-199802000-00047, 9482179.
19. Schoettle RJ, Kochanek PM, Magargee MJ, Uhl MW, Nemoto EM. Early polymorphonuclear leukocyte accumulation correlates with the development of posttraumatic cerebral edema in rats. J Neurotrauma 1990, 7:207-217. 10.1089/neu.1990.7.207, 2127947.
20. Schürer L, Grögaard B, Gerdin B, Arfors KE. Effects of neutrophil depletion and superoxide dismutase on postischemic hypoperfusion of rat brain. Adv Neurol 1990, 52:57-62.
21. Dinkel K, Dhabhar FS, Sapolsky RM. Neurotoxic effects of polymorphonuclear granulocytes on hippocampal primary cultures. Proc Natl Acad Sci USA 2004, 101:331-336. 10.1073/pnas.0303510101, 314185, 14684829.
22. Emerich DF, Dean RL, Bartus RT. The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct?. Exp Neurol 2002, 173:168-181. 3, 10.1006/exnr.2001.7835, 11771949.
23. Morganti-Kossmann MC, Rancan M, Stahel PF, Kossmann T. Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit Care 2002, 8:101-105. 10.1097/00075198-200204000-00002, 12386508.
24. Ransohoff RM, Kivisäkk P, Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 2003, 3:569-581. 10.1038/nri1130, 12876559.
25. Babcock AA, Kuziel WA, Rivest S, Owens T. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 2003, 23:7922-7930.
26. Bell MD, Taub DD, Kunkel SJ, Strieter RM, Foley R, Gauldie J, Perry VH. Recombinant human adenovirus with rat MIP-2 gene insertion causes prolonged PMN recruitment to the murine brain. Eur J Neurosci 1996, 8:1803-1811. 10.1111/j.1460-9568.1996.tb01324.x, 8921271.
27. Zwijnenburg PJ, Polfliet MM, Florquin S, van den Berg TK, Dijkstra CD, van Deventer SJ, Roord JJ, van der Poll T, van Furth AM. CXC-chemokines KC and macrophage inflammatory protein-2 (MIP-2) synergistically induce leukocyte recruitment to the central nervous system in rats. Immunol Lett 2003, 85:1-4. 10.1016/S0165-2478(02)00200-6, 12505189.
28. Hayashi M, Luo Y, Laning J, Strieter RM, Dorf ME. Production and function of monocyte chemoattractant protein-1 and other beta-chemokines in murine glial cells. J Neuroimmunol 1995, 60:143-150. 10.1016/0165-5728(95)00064-9, 7642742.
29. Otto VI, Heinzel-Pleines UE, Gloor SM, Trentz O, Kossmann T, Morganti-Kossmann MC. sICAM-1 and TNF-alpha induce MIP-2 with distinct kinetics in astrocytes and brain microvascular endothelial cells. J Neurosci Res 2000, 60:733-742. 10.1002/1097-4547(20000615)60:6<733::AID-JNR5>3.0.CO;2-X, 10861785.
30. Rhodes JK, Sharkey J, Andrews PJ. The temporal expression, cellular localization, and inhibition of the chemokines MIP-2 and MCP-1 after traumatic brain injury in the rat. J Neurotrauma 2009, 26:507-525. 10.1089/neu.2008.0686, 19210118.
31. McLarnon JG, Ryu JK, Walker DG, Choi HB. Upregulated expression of purinergic P2X7 receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in peptide-injected rat hippocampus. J Neuropathol Exp Neurol 2006, 65:1090-1097. 10.1097/01.jnen.0000240470.97295.d3, 17086106.
32. Melani A, Amadio S, Gianfriddo M, Vannucchi MG, Volontè C, Bernardi G, Pedata F, Sancesario G. P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat. J Cereb Blood Flow Metab 2006, 26:974-982. 10.1038/sj.jcbfm.9600250, 16395292.
33. Parvathenani LK, Tertyshnikova S, Greco CR, Roberts SB, Robertson B, Posmantur R. P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J Biol Chem 2003, 278:13309-13317. 10.1074/jbc.M209478200, 12551918.
34. Rappold PM, Lynd-Balta E, Joseph SA. P2X7 receptor immunoreactive profile confined to resting and activated microglia in the epileptic brain. Brain Res 2006, 1089:171-178. 10.1016/j.brainres.2006.03.040, 16635480.
35. Brough D, Le Feuvre RA, Iwakura Y, Rothwell NJ. Purinergic: Purinergic (P2X7) receptor activation of microglia induces cell death via an interleukin-1-independent mechanism. Mol Cell Neurosci 2002, 19:272-280. 10.1006/mcne.2001.1054, 11860279.
36. Chakfe Y, Seguin R, Antel JP, Morissette C, Malo D, Henderson D, Séguéla P. ADP and AMP induce interleukin-1beta release from microglial cells through activation of ATP-primed P2X7 receptor channels. J Neurosci 2002, 22:3061-3069.
37. Le Feuvre RA, Brough D, Touzani O, Rothwell NJ. Role of P2X7 receptors in ischemic and excitotoxic brain injury in vivo. J Cereb Blood Flow Metab 2003, 23:381-384. 10.1097/00004647-200303000-00013, 12621313.
38. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 1997, Academic Press, San Diego, 3.
39. Pencea V, Bingaman KD, Wiegand SJ, Luskin MB. Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. J Neurosci 2001, 21:6706-6717.
40. Siuciak JA, Boylan C, Fritsche M, Altar CA, Lindsay RM. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Res 1996, 710:11-20. 10.1016/0006-8993(95)01289-3, 8963648.
41. Ryu HJ, Kim JE, Kim MJ, Kwon HJ, Suh SW, Song HK, Kang TC. The protective effects of interleukin-18 and interferon-gamma on neuronal damages in the rat hippocampus following status epilepticus. Neuroscience 2010, 170:711-721. 10.1016/j.neuroscience.2010.07.048, 20674684.
42. Kim JE, Kwak SE, Choi SY, Kang TC. Region-specific alterations in astroglial TWIK-related acid-sensitive K+-1 channel immunoreactivity in the rat hippocampal complex following pilocarpine-induced status epilepticus. J Comp Neurol 2008, 510:463-474. 10.1002/cne.21767, 18671295.
43. Kim JE, Kwak SE, Kang TC. Upregulated TWIK-related acid-sensitive K+ channel-2 in neurons and perivascular astrocytes in the hippocampus of experimental temporal lobe epilepsy. Epilepsia 2009, 50:654-663. 10.1111/j.1528-1167.2008.01957.x, 19220408.
44. Kang TC, Kim DS, Kwak SE, Kim JE, Won MH, Kim DW, Choi SY, Kwon OS. Epileptogenic roles of astroglial death and regeneration in the dentate gyrus of experimental temporal lobe epilepsy. Glia 2006, 54:258-271. 10.1002/glia.20380, 16845674.
45. Wang G, Achim CL, Hamilton RL, Wiley CA, Soontornniyomkij V. Tyramide signal amplification method in multiple-label immunofluorescence confocal microscopy. Methods 1999, 18:459-464. 10.1006/meth.1999.0813, 10491275.
46. Ravizza T, Gagliardi B, Noé F, Boer K, Aronica E, Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 2008, 29:142-160. 10.1016/j.nbd.2007.08.012, 17931873.
47. Kielian T, Barry B, Hickey WF. CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses. J Immunol 2001, 166:4634-4643.
48. Lévy P, Lettéron P, Paye F, Molas G, Guimont MC, Pessayre D, Bernades P, Rozé C. In vivo assessment of lipid peroxidation in experimental edematous and necrotizing rat pancreatitis. Pancreas 1997, 14:350-354. 10.1097/00006676-199705000-00004, 9163780.
49. Hinshaw DB, Burger JM, Delius RE, Hyslop PA. Mechanism of protection of oxidant-injured endothelial cells by glutamine. Surgery 1990, 108:298-305.
50. Hyslop PA, Hinshaw DB, Halsey WA, Schraufstätter IU, Sauerheber RD, Spragg RG, Jackson JH, Cochrane CG. Mechanisms of oxidant-mediated cell injury. The glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. J Biol Chem 1988, 263:1665-1675.
51. Tsuji T, Nagata K, Koike J, Todoroki N, Irimura T. Induction of superoxide anion production from monocytes and neutrophils by activated platelets through the P-selectin-sialyl Lewis X interaction. J Leukoc Biol 1994, 56:583-587.
52. Dale DC, Boxer L, Liles WC. The phagocytes: neutrophils and monocytes. Blood 2008, 112:935-945. 10.1182/blood-2007-12-077917, 18684880.
53. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 1994, 91:3652-3656. 10.1073/pnas.91.9.3652, 43639, 8170963.
54. Fuentes ME, Durham SK, Swerdel MR, Lewin AC, Barton DS, Megill JR, Bravo R, Lira SA. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol 1995, 155:5769-5776.
55. Busch-Petersen J. Small molecule antagonists of the CXCR2 and CXCR1 chemokine receptors as therapeutic agents for the treatment of inflammatory diseases. Curr Top Med Chem 2006, 6:1345-1352.
56. Shaftel SS, Carlson TJ, Olschowka JA, Kyrkanides S, Matousek SB, O'Banion MK. Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration. J Neurosci 2007, 27:9301-9309. 10.1523/JNEUROSCI.1418-07.2007, 17728444.
57. Schilling M, Strecker JK, Schäbitz WR, Ringelstein EB, Kiefer R. Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice. Neuroscience 2009, 161:806-812. 10.1016/j.neuroscience.2009.04.025, 19374937.
58. Peng W, Cotrina ML, Han X, Yu H, Bekar L, Blum L, Takano T, Tian GF, Goldman SA, Nedergaard M. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc Natl Acad Sci USA 2009, 106:12489-12493. 10.1073/pnas.0902531106, 2718350, 19666625.
59. Ramprasad MP, Terpstra V, Kondratenko N, Quehenberger O, Steinberg D. Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci USA 1996, 93:14833-14838. 10.1073/pnas.93.25.14833, 26222, 8962141.
60. Deininger MH, Pater S, Strik H, Meyermann R. Macrophage/microglial cell subpopulations in glioblastoma multiforme relapses are differentially altered by radiochemotherapy. J Neurooncol 2001, 55:141-147. 10.1023/A:1013805915224, 11859968.
61. Caffo M, Caruso G, Germanò A, Galatioto S, Meli F, Tomasello F. CD68 and CR3/43 immunohistochemical expression in secretory meningiomas. Neurosurgery 2005, 57:551-557. 10.1227/01.NEU.0000170440.32720.77, 16145535.
62. Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2001, 2:734-744. 10.1038/35094583, 11584311.
63. Loddick SA, Rothwell NJ. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 1996, 16:932-940. 10.1097/00004647-199609000-00017, 8784237.
64. Rizzi M, Perego C, Aliprandi M, Richichi C, Ravizza T, Colella D, Velískǒvá J, Moshé SL, De Simoni MG, Vezzani A. Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development. Neurobiol Dis 2003, 14:494-503. 10.1016/j.nbd.2003.08.001, 14678765.
65. Anthony DC, Bolton SJ, Fearn S, Perry VH. Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain 1997, 120:435-444. 10.1093/brain/120.3.435, 9126055.
66. Ching S, He L, Lai W, Quan N. IL-1 type I receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system. Brain Behav Immun 2005, 19:127-137. 10.1016/j.bbi.2004.06.001, 15664785.
67. Depino A, Ferrari C, Pott MC, Tarelli R, Pitossi FJ. Differential effects of interleukin-1beta on neurotoxicity, cytokine induction and glial reaction in specific brain regions. J Neuroimmunol 2005, 168:96-110. 10.1016/j.jneuroim.2005.07.009, 16112750.
68. Ferrari CC, Depino AM, Prada F, Muraro N, Campbell S, Podhajcer O, Perry VH, Anthony DC, Pitossi FJ. Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. Am J Pathol 2004, 165:1827-1837. 1618664, 15509551.
69. Proescholdt MG, Chakravarty S, Foster JA, Foti SB, Briley EM, Herkenham M. Intracerebroventricular but not intravenous interleukin-1beta induces widespread vascular-mediated leukocyte infiltration and immune signal mRNA expression followed by brain-wide glial activation. Neuroscience 2002, 112:731-749. 10.1016/S0306-4522(02)00048-9, 12074914.
70. Bernardino L, Balosso S, Ravizza T, Marchi N, Ku G, Randle JC, Malva JO, Vezzani A. Inflammatory events in hippocampal slice cultures prime neuronal susceptibility to excitotoxic injury: a crucial role of P2X7 receptor-mediated IL-1beta release. J Neurochem 2008, 106:271-280. 10.1111/j.1471-4159.2008.05387.x, 18384650.
71. Sanz JM, Chiozzi P, Ferrari D, Colaianna M, Idzko M, Falzoni S, Fellin R, Trabace L, Di Virgilio F. Activation of microglia by amyloid {beta} requires P2X7 receptor expression. J Immunol 2009, 182:4378-4385. 10.4049/jimmunol.0803612, 19299738.
72. Takenouchi T, Sugama S, Iwamaru Y, Hashimoto M, Kitani H. Modulation of the ATP-lnduced release and processing of IL-1beta in microglial cells. Crit Rev Immunol 2009, 29:335-345.
73. Anthony D, Dempster R, Fearn S, Clements J, Wells G, Perry VH, Walker K. CXC chemokines generate age-related increases in neutrophil-mediated brain inflammation and blood-brain barrier breakdown. Curr Biol 1998, 8:923-926. 10.1016/S0960-9822(07)00373-9, 9707404.
74. Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M, Galli CL, Marinovich M. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 2003, 23:8692-8700.
75. Ye ZC, Sontheimer H. Cytokine modulation of glial glutamate uptake: a possible involvement of nitric oxide. Neuroreport 1996, 7:2181-2185. 10.1097/00001756-199609020-00025, 8930985.
76. Hu S, Sheng WS, Ehrlich LC, Peterson PK, Chao CC. Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 2000, 7:153-159. 10.1159/000026433, 10754403.
77. Casamenti F, Prosperi C, Scali C, Giovannelli L, Colivicchi MA, Faussone-Pellegrini MS, Pepeu G. Interleukin-1beta activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's disease. Neuroscience 1999, 91:831-842. 10.1016/S0306-4522(98)00680-0, 10391466.
78. Kim JE, Choi HC, Song HK, Jo SM, Kim DS, Choi SY, Kim YI, Kang TC. Levetiracetam inhibits interleukin-1 beta inflammatory responses in the hippocampus and piriform cortex of epileptic rats. Neurosci Lett 2010, 471:94-99. 10.1016/j.neulet.2010.01.018, 20080147.
79. Ali DW, Salter MW. NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity. Curr Opin Neurobiol 2001, 11:336-342. 10.1016/S0959-4388(00)00216-6, 11399432.
80. Dubé C, Vezzani A, Behrens M, Bartfai T, Baram TZ. Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann Neurol 2005, 57:152-155. 10.1002/ana.20358, 2909879, 15622539.
81. Allan SM, Tyrrell PJ, Rothwell NJ. Interleukin-1 and neuronal injury. Nat Rev Immunol 2005, 5:629-640. 10.1038/nri1664, 16034365.
82. Hailer NP, Vogt C, Korf HW, Dehghani F. Interleukin-1beta exacerbates and interleukin-1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic hippocampal slice cultures. Eur J Neurosci 2005, 21:2347-2360. 10.1111/j.1460-9568.2005.04067.x, 15932594.
83. Patel HC, Ross FM, Heenan LE, Davies RE, Rothwell NJ, Allan SM. Neurodegenerative actions of interleukin-1 in the rat brain are mediated through increases in seizure activity. J Neurosci Res 2006, 83:385-391. 10.1002/jnr.20735, 16358339.
84. Rothwell N. Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential. Brain Behav Immun 2003, 17:152-157. 10.1016/S0889-1591(02)00098-3, 12706413.
85. Emerson MR, Nelson SR, Samson FE, Pazdernik TL. Hypoxia preconditioning attenuates brain edema associated with kainic acid-induced status epilepticus in rats. Brain Res 1999, 825:189-193. 10.1016/S0006-8993(99)01195-6, 10216187.